These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21093442)

  • 1. Structural basis of CX-4945 binding to human protein kinase CK2.
    Ferguson AD; Sheth PR; Basso AD; Paliwal S; Gray K; Fischmann TO; Le HV
    FEBS Lett; 2011 Jan; 585(1):104-10. PubMed ID: 21093442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
    Sekiguchi Y; Nakaniwa T; Kinoshita T; Nakanishi I; Kitaura K; Hirasawa A; Tsujimoto G; Tada T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2920-3. PubMed ID: 19414254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven.
    Raaf J; Brunstein E; Issinger OG; Niefind K
    Protein Sci; 2008 Dec; 17(12):2180-6. PubMed ID: 18824508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer.
    Battistutta R; Cozza G; Pierre F; Papinutto E; Lolli G; Sarno S; O'Brien SE; Siddiqui-Jain A; Haddach M; Anderes K; Ryckman DM; Meggio F; Pinna LA
    Biochemistry; 2011 Oct; 50(39):8478-88. PubMed ID: 21870818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational dynamics of human protein kinase CK2α and its effect on function and inhibition.
    Srivastava A; Hirota T; Irle S; Tama F
    Proteins; 2018 Mar; 86(3):344-353. PubMed ID: 29243286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants of CX-4945 derivatives as protein kinase CK2 inhibitors: a computational study.
    Liu H; Wang X; Wang J; Wang J; Li Y; Yang L; Li G
    Int J Mol Sci; 2011; 12(10):7004-21. PubMed ID: 22072932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Pivotal Role of the CK2 Hinge Region Sub-Pocket in Binding with Tricyclic Quinolone Analogues by Computational Analysis.
    Zhou Y; Zhang N; Tang S; Qi X; Zhao L; Zhong R; Peng Y
    Molecules; 2017 May; 22(5):. PubMed ID: 28534839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate.
    Yde CW; Ermakova I; Issinger OG; Niefind K
    J Mol Biol; 2005 Mar; 347(2):399-414. PubMed ID: 15740749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.
    Siddiqui-Jain A; Drygin D; Streiner N; Chua P; Pierre F; O'Brien SE; Bliesath J; Omori M; Huser N; Ho C; Proffitt C; Schwaebe MK; Ryckman DM; Rice WG; Anderes K
    Cancer Res; 2010 Dec; 70(24):10288-98. PubMed ID: 21159648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligand.
    Raaf J; Guerra B; Neundorf I; Bopp B; Issinger OG; Jose J; Pietsch M; Niefind K
    ACS Chem Biol; 2013 May; 8(5):901-7. PubMed ID: 23474121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.
    Pietsch M; Viht K; Schnitzler A; Ekambaram R; Steinkrüger M; Enkvist E; Nienberg C; Nickelsen A; Lauwers M; Jose J; Uri A; Niefind K
    Bioorg Chem; 2020 Mar; 96():103608. PubMed ID: 32058103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds.
    Hou Z; Nakanishi I; Kinoshita T; Takei Y; Yasue M; Misu R; Suzuki Y; Nakamura S; Kure T; Ohno H; Murata K; Kitaura K; Hirasawa A; Tsujimoto G; Oishi S; Fujii N
    J Med Chem; 2012 Mar; 55(6):2899-903. PubMed ID: 22339433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
    Raaf J; Klopffleisch K; Issinger OG; Niefind K
    J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and design of tricyclic scaffolds as protein kinase CK2 (CK2) inhibitors through a combination of shape-based virtual screening and structure-based molecular modification.
    Sun H; Xu X; Wu X; Zhang X; Liu F; Jia J; Guo X; Huang J; Jiang Z; Feng T; Chu H; Zhou Y; Zhang S; Liu Z; You Q
    J Chem Inf Model; 2013 Aug; 53(8):2093-102. PubMed ID: 23937544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.
    Battistutta R
    Cell Mol Life Sci; 2009 Jun; 66(11-12):1868-89. PubMed ID: 19387547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GTP plus water mimic ATP in the active site of protein kinase CK2.
    Niefind K; Pütter M; Guerra B; Issinger OG; Schomburg D
    Nat Struct Biol; 1999 Dec; 6(12):1100-3. PubMed ID: 10581548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.
    Ermakova I; Boldyreff B; Issinger OG; Niefind K
    J Mol Biol; 2003 Jul; 330(5):925-34. PubMed ID: 12860116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity.
    Masłyk M; Janeczko M; Martyna A; Kubiński K
    Mol Cell Biochem; 2017 Nov; 435(1-2):193-196. PubMed ID: 28501934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'.
    Bischoff N; Raaf J; Olsen B; Bretner M; Issinger OG; Niefind K
    Mol Cell Biochem; 2011 Oct; 356(1-2):57-65. PubMed ID: 21739153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CK2α and CK2α' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives.
    Janeczko M; Orzeszko A; Kazimierczuk Z; Szyszka R; Baier A
    Eur J Med Chem; 2012 Jan; 47(1):345-50. PubMed ID: 22115617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.